13 results on '"Janssen, Jeroen J. W. M."'
Search Results
2. Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival.
3. Reply to the Comment on Association of FLT3 -internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
4. Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population.
5. Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis.
6. The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era.
7. Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity.
8. Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival.
9. Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemia.
10. Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia.
11. Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.
12. Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells.
13. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.